Genky DrugStores Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended June 20, 2019; Provides Earnings Guidance for the First Half and Fiscal Year 2020
July 18, 2019
Share
Genky DrugStores Co., Ltd. reported consolidated and non-consolidated earnings results for the year ended June 20, 2019. For the year, the consolidated company reported net sales of ¥103,897 million compared to ¥94,869 million a year ago. Operating income was ¥4,046 million compared to ¥4,128 million a year ago. Net income attributable to owners of parent was ¥2,697 million or ¥174.70 per share compared to ¥3,118 million or ¥206.55 per share a year ago.
For the year, the non-consolidated company reported net sales of ¥244 million compared to ¥122 million a year ago. Operating income was ¥8 million compared to ¥37 million a year ago. Net income was ¥6 million or ¥0.44 per share compared to ¥927 million or ¥61.40 per share a year ago.
The company provided earnings guidance for the first half and fiscal year 2020. For the first half, the company expects net sales of ¥56,500 million, operating income was ¥1,550 million and net income attributable to owners of parent of ¥1,200 million or ¥79.07 per share.
For the year ending June 20, 2019, the company expects net sales of ¥115,000 million, operating income was ¥4,050 million and net income attributable to owners of parent of ¥3,000 million or ¥197.66 per share.
Genky DrugStores Co Ltd is mainly engaged in the management of group companies and the related business. The Company is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
Genky DrugStores Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended June 20, 2019; Provides Earnings Guidance for the First Half and Fiscal Year 2020